Cytomegalovirus-related disease is a risk factor of acute rejection in renal transplant recipients: A case-controlled study;La maladie a cytomegalovirus, facteur de risque de rejet aigu d'allogreffe renale: Etude exposes/non exposes

Presse Medicale

Volumn 28, Issue 12, 1999, Pages 619-624

  Bouedjoro Camus, M C ^a   Novella, J L ^b   Toupance, O ^d   Wynckel, A ^d   Carquin, J ^c   Jolly, D ^d   Chanard, J ^d  

^a Polyclinique Saint André ^*  (France)

^b Hopital Sebastopol   (France)

^c SERVICE DE DERMATOLOGIE   (France)

^d HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; KIDNEY GRAFT REJECTION; RECIPIENT; RISK FACTOR; ADULT; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL DISTRIBUTION;

ADULT; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; STATISTICAL DISTRIBUTIONS;

EID: 0033608714     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hofmann GO, Schneeberger H, Land W. Risk factors for chronic transplant failure after kidney transplantation. Transplant Proc 1995 ; 27:2031-2.
2. Kumar MSA, Cridge P, Molavi A. Infectious complications in the first 100 days after renal transplantation. Transplant Proc 1995;27:2705-6.
3. Martinez Marcos F, Cisneros J, Gentil M et al. Prospective study of renal transplant infections in 50 consecutive patients. Eur J Clin Microbiol Infect Dis 1994 ; 13:1023-8.
4. Weimar W, Balk A, Matselaar HJ, Mochtar B, Rothbarth PH. On the relation between cytomegalovirus infection and rejection after heart transplantation. Transplantation 1991 ; 52:162-4.
5. Bruning JH, Bruggeman CA, Van Breda Vriesman PJ. The effect of cytomegalovirus infection on renal allograft function and rejection in a rat model. Transplantation 1989 ; 47:742-4.
6. Marker SC, Howard RJ, Simmons RL et al. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. Surgery 1981 ; 89:660-70.
7. Cantarovich D, Le Sant JN. CMV et transplantation rénale. La lettre de l'infectiologue 1994 ; février : 2-44.
8. Couchoud C, Cucherat M, Haugh M, Pouteil-Noble C. Cytomégalovirus prophylaxis with antiviral agents in solid organ transplant. A meta analysis. Transplantation 1998;65:641-7.
9. Lautenschlager I, Soots A, Krogerus L et al. Effects of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple drug treatment in the rat. Transplantation 1997 ; 64:391-8.
10. Yilmaz S, Koskinen PK, Kallio E, Bruggeman CA, Hayry PJ, Lemstrom KB. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 1996 ; 50:526-37.
11. Zilow G, Haffner D, Roelcke D. CMV-induced anti-sia-b1 cold agglutinin in an immunocompromised patient. Beitr Infusionsther Transfusionsmed 1997 ; 34: 180-4.
12. Nakayama Y, Abe H, Rapaport FT, Waltzer WC, Kakita A. Influence of donor factors other than serologic status on transmission of cytomegalovirus to renal transplant recipients. Transplant Proc 1994 ; 26:936-7.
13. Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG. Effects of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. Ann Intern Med 1997 ; 126:275-9.
14. Pouria S, State OI, Wong W, Hendry BM. CMV infection is associated with transplant renal artery stenosis. QJM 1998 ; 91(3):185-9.
15. Rubin RH. Impact of cytomegalovirus infection om organ transplant recipients. Rev Infect Dis 1990 ; 12:754-66.
16. Pouteil Noble N, Ecochard R, Landrivon G et al. Cytomegalovirus infection - an etiological factor for rejection? Transplantation 1993 ; 55:851-7.
17. Tough D, Borrow P, Sprent J. Induction of bystander T cell proliferative by viruses and type I interferon in vivo. Science 1996 ; 272: 1947-50.
18. Nahill S, Welsh R. High frequency of cross reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response J Exp Med 1993 ; 177:317-27.
19. Lebranchu Y, Al Najjar A, Kapah I et al. The association of increased soluble VCAM-1 levels with CMV disease in human kidney allograft recipients. Transplant Proc 1995 ; 27:960-70.
20. Fuggle SV, Koo DDH. Cell adhesion molecules in clinical renal transplantation. Transplantation 1998 ; 65:753-9.
21. Freymuth F, Petitjean J, Eugene-Ruelland G, Daon F, Galateau F. Infection à cytomégalovirus après transplantation: diagnostic virologique, traitement antiviral. Path Biol 1993 ; 41:724-30.
22. Solez K, Axelsen RA, Bendiktsson H. et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993 ; 44:411-22.
23. Busson M, N'Doye P, Benoit G et al. Donor factors influencing organ transplant prognosis. Transplant Proc 1995 ; 27:1662-4
24. Hökeberg I, Eriksson BM, Zweygberg-Wirgart B, Tufvesson G, Olding-Stenkvist E, Grillner L. Diagnostic markers and risk factors of cytomegalovirus infection and disease in renal allograft recipients. Scand J Infect Dis 1995 ; 27:435-40.
25. Craigen JL, Grundy JE. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation 1996 ; 62:1102-8.
26. Sedmark D, Knight DA, Vook NC, Waldman JW. Divergent patterns of ELAM-1, ICAM-1 and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994 ; 58:1379-85.
27. Van Dorp WT, Van Wieringen PAM, Marselis-Jonges E et al. Cytomegalovirus directly enhances mhc class i and intercellular adhesion molecule-1 expression on cultured passional tubular epithelial cells. Transplantation 1993 ; 55:1367-71.
28. Ahsan N, Holman MJ, Yang HC. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patents. Clin Transplant 1997; 11:633-9.
29. Conti DJ, Freed BM, Singh TP, Gallichio M, Gruber SA, Lempert N. Preemptive ganciclovir therapy in cytomegalovirus seropositive renal transplant recipients. Arch Surg 1995 ; 130:1217-22.
30. Lewance D, Legendre C, Neumayer HH, et al. Valaciclovir reduces the incidenceof cytomegalovirus disease and acute graft rejection in CMV seronegative recipients of a seropositive cadaveric renal allograft. Transplan-tation 1998 ; 65:S18 (abstract).